Warning letter

SeniorLife Health Inc.: warning letter of Aug 21, 2008

FDA warning letter UCM172852 · Los Angeles District Office

Key facts

Reference number UCM172852
Company SeniorLife Health Inc.
Subject New Drug/Misbranded
Issue date Aug 21, 2008
Posted date Aug 21, 2008
Issuing office Los Angeles District Office
Product type Drugs
Country 3
Letter on fda.gov web.archive.org

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters